Coherus BioSciences Announces New Employment Inducement Grants
- None.
- None.
REDWOOD CITY, Calif., Dec. 22, 2023 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus” or the “Company”, Nasdaq: CHRS), today announced that effective December 20, 2023, the compensation committee of the Company’s board of directors granted options to purchase an aggregate of 192,000 shares of the common stock of the Company to five newly hired employees with a per share exercise price of
The stock options were granted pursuant to the Coherus BioSciences, Inc. 2016 Employment Commencement Incentive Plan, which was approved by the Company’s board of directors in June 2016 under Rule 5635(c)(4) of the Nasdaq Global Select Market for equity grants to induce new employees to enter into employment with the Company.
Coherus BioSciences Contact Information:
IR Contact
Jami Taylor, Head of Investor Relations
Coherus BioSciences, Inc.
IR@coherus.com
FAQ
What did Coherus BioSciences announce on December 22, 2023?
How many shares of common stock were included in the options granted?
Under which plan were the stock options granted?